281 related articles for article (PubMed ID: 18221142)
1. Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux.
Van Bambeke F; Pagès JM; Lee VJ
Recent Pat Antiinfect Drug Discov; 2006 Jun; 1(2):157-75. PubMed ID: 18221142
[TBL] [Abstract][Full Text] [Related]
2. Bacterial efflux pumps involved in multidrug resistance and their inhibitors: rejuvinating the antimicrobial chemotherapy.
Bhardwaj AK; Mohanty P
Recent Pat Antiinfect Drug Discov; 2012 Apr; 7(1):73-89. PubMed ID: 22353004
[TBL] [Abstract][Full Text] [Related]
3. [The importance of efflux systems in antibiotic resistance and efflux pump inhibitors in the management of resistance].
Aygül A
Mikrobiyol Bul; 2015 Apr; 49(2):278-91. PubMed ID: 26167829
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic Adjuvants: Rescuing Antibiotics from Resistance.
Wright GD
Trends Microbiol; 2016 Nov; 24(11):862-871. PubMed ID: 27430191
[TBL] [Abstract][Full Text] [Related]
5. The analysis of the antibiotic resistome offers new opportunities for therapeutic intervention.
Corona F; Blanco P; Alcalde-Rico M; Hernando-Amado S; Lira F; Bernardini A; Sánchez MB; Martínez JL
Future Med Chem; 2016 Jun; 8(10):1133-51. PubMed ID: 27304087
[TBL] [Abstract][Full Text] [Related]
6. [Efflux pumps: their role in Staphylococcus aureus antibiotic resistance].
Doléans-Jordheim A; Michalet S; Bergeron E; Boisset S; Souard F; Dumontet C; Dijoux-Franca MG; Freney J
Ann Biol Clin (Paris); 2008; 66(5):499-508. PubMed ID: 18957338
[TBL] [Abstract][Full Text] [Related]
7. Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view.
Lynch AS
Biochem Pharmacol; 2006 Mar; 71(7):949-56. PubMed ID: 16290174
[TBL] [Abstract][Full Text] [Related]
8. Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review.
Annunziato G
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766441
[TBL] [Abstract][Full Text] [Related]
9. Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria.
Wang Y; Venter H; Ma S
Curr Drug Targets; 2016; 17(6):702-19. PubMed ID: 26424403
[TBL] [Abstract][Full Text] [Related]
10. The intrinsic resistance of bacteria.
Zhang G; Feng J
Yi Chuan; 2016 Oct; 38(10):872-880. PubMed ID: 27806928
[TBL] [Abstract][Full Text] [Related]
11. Medicinal Chemistry Updates on Bacterial Efflux Pump Modulators.
Durães F; Pinto M; Sousa E
Curr Med Chem; 2018; 25(42):6030-6069. PubMed ID: 29424299
[TBL] [Abstract][Full Text] [Related]
12. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.
Adamson DH; Krikstopaityte V; Coote PJ
J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of multidrug resistant efflux systems in bacteria.
Zechini B; Versace I
Recent Pat Antiinfect Drug Discov; 2009 Jan; 4(1):37-50. PubMed ID: 19149695
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy.
Mahamoud A; Chevalier J; Alibert-Franco S; Kern WV; Pagès JM
J Antimicrob Chemother; 2007 Jun; 59(6):1223-9. PubMed ID: 17229832
[TBL] [Abstract][Full Text] [Related]
15. Bacterial Multidrug Efflux Pumps of the Major Facilitator Superfamily as Targets for Modulation.
Kumar S; He G; Kakarla P; Shrestha U; Ranjana KC; Ranaweera I; Willmon TM; Barr SR; Hernandez AJ; Varela MF
Infect Disord Drug Targets; 2016; 16(1):28-43. PubMed ID: 27052334
[TBL] [Abstract][Full Text] [Related]
16. Efflux pump inhibitors for bacterial pathogens: From bench to bedside.
Sharma A; Gupta VK; Pathania R
Indian J Med Res; 2019 Feb; 149(2):129-145. PubMed ID: 31219077
[TBL] [Abstract][Full Text] [Related]
17. Extending the Potency and Lifespan of Antibiotics: Inhibitors of Gram-Negative Bacterial Efflux Pumps.
Duffey M; Jumde RP; da Costa RMA; Ropponen HK; Blasco B; Piddock LJV
ACS Infect Dis; 2024 May; 10(5):1458-1482. PubMed ID: 38661541
[TBL] [Abstract][Full Text] [Related]
18. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V
Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
[TBL] [Abstract][Full Text] [Related]
19. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
Goli HR; Nahaei MR; Rezaee MA; Hasani A; Kafil HS; Aghazadeh M; Nikbakht M; Khalili Y
J Infect Public Health; 2018; 11(3):364-372. PubMed ID: 28993173
[TBL] [Abstract][Full Text] [Related]
20. Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux Pumps.
Mahmood HY; Jamshidi S; Sutton JM; Rahman KM
Curr Med Chem; 2016; 23(10):1062-81. PubMed ID: 26947776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
